The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies
Open accessAbstract
Hedonistic homeostatic dysregulation is a neuropsychological behavioural disorder associated with substance misuse and addiction. The disorder has been recognised as a consequence of dopamine replacement therapy (DRT) in 15 patients with Parkinson's disease. The syndrome typically develops in male patients with early onset Parkinson's disease, and can occur with orally and subcutaneously administered DRT. These patients take increasing quantities of their DRT, despite increasingly severe drug induced dyskinesias, and may develop a cyclical mood disorder with hypomania or manic psychosis. There is impairment of social and occupational functioning. Tolerance develops to mood elevating effects of DRT and a negative affective withdrawal state occurs if the drugs are withdrawn or doses decreased. The clinical features and guidelines for managing this syndrome are discussed. A set of diagnostic criteria for further investigating this condition is proposed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Drug abuse: hedonic homeostatic dysregulation
Koob, G. F., & Moal, M. L. (1997) · Science · doi:10.1126/science.278.5335.52 · Cited by 2,535 · cited 1×
“13 In addition to the neuropharmacological and behavioural similarities between DRT and stimulant misuse, there is an overlap in their motor manifestations.”
BackgroundCellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
Electrical Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease
Limousin, P., Krack, P., Pollak, P., Benazzouz, A., Ardouin, C., Hoffmann, D., & Benabid, A.-L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810153391603 · Cited by 1,853
Neuropathology of Parkinsonʼs Disease
Forno, L. S. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199603000-00001 · Cited by 1,465
The Tridimensional Personality Questionnaire: U.S. Normative Data
Cloninger, C. R., Przybeck, T. R., & Svrakic, D. M. (1991) · Psychological Reports · doi:10.2466/pr0.1991.69.3.1047 · Cited by 1,034
The pharmacology of cocaine related to its abuse.
Johanson, C. E., & Fischman, M. W. (1989) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00022-5 · Cited by 686
Mechanisms of Amphetamine Action Revealed in Mice Lacking the Dopamine Transporter
Jones, S. R., Gainetdinov, R. R., Wightman, R. M., & Caron, M. G. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-06-01979.1998 · Cited by 631
Effects of chronic cocaine abuse on postsynaptic dopamine receptors
(1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.6.719 · Cited by 421
Midbrain dopaminergic cell loss in parkinson's disease: Computer visualization
German, D. C., Manaye, K., Smith, W. K., Woodward, D. J., & Saper, C. B. (1989) · Annals of Neurology · doi:10.1002/ana.410260403 · Cited by 396
The response to levodopa in parkinson's disease: Imposing pharmacological law and order
Nutt, J. G., & Holford, N. H. G. (1996) · Annals of Neurology · doi:10.1002/ana.410390504 · Cited by 299
Dopamine‐related personality traits in Parkinson's disease
Menza, M. A., Golbe, L. I., Cody, R. A., & Forman, N. E. (1993) · Neurology · doi:10.1212/wnl.43.3_part_1.505 · Cited by 247
Colzi, A., Turner, K., & Lees, A. J. (1998) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.5.573 · Cited by 225
Hypersexuality with Antiparkinsonian Therapy
Uitti, R. J., Tanner, C. M., Rajput, A. H., Goetz, C. G., Klawans, H. L., & Thiessen, B. (1989) · Clinical Neuropharmacology · doi:10.1097/00002826-198910000-00002 · Cited by 213
Neurochemical changes in cocaine withdrawal
Kuhar, M. J., & Pilotte, N. S. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)10024-9 · Cited by 159
Psychoses and the punding and choreiform syndromes in addiction to central stimulant drugs.
Rylander, G. (1972) · PubMed · Cited by 151
Apomorphine‐induced penile erections in Parkinson's disease
O’Sullivan, J. D., & Hughes, A. J. (1998) · Movement Disorders · doi:10.1002/mds.870130326 · Cited by 120
Cocaine‐related movement disorders
Cardoso, F., & Jankovic, J. J. (1993) · Movement Disorders · doi:10.1002/mds.870080210 · Cited by 101
Psychopathology Induced by “Speed Drugs”
Schiørring, E. (1981) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(81)80018-4 · Cited by 91
Hypersexuality - a Complication of Dopaminergic Therapy in Parkinson's Disease
Vogel, H. P., & Schiffter, R. (1983) · Pharmacopsychiatry · doi:10.1055/s-2007-1017459 · Cited by 81
Levodopa: Alterations in behavior
Goodwin, F. K., Murphy, D. L., Brodie, H. K. H., & Bunney, W. E. (1971) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1971122part2383 · Cited by 67
Psychiatric and Sexual Disorders Induced by Apomorphine in Parkinsonʼs Disease
Courty, E., Durif, F., Zénut, M., Courty, P., & Lavarenne, J. (1997) · Clinical Neuropharmacology · doi:10.1097/00002826-199704000-00005 · Cited by 64
Strang, J., & Edwards, G. (1989) · BMJ · doi:10.1136/bmj.299.6695.337 · Cited by 56
Pathological gambling in Parkinson's disease
Stocchi, F. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70177-0 · Cited by 40
Trulson, M. E., Babb, S., Joe, J. C., & Raese, J. D. (1986) · Experimental Neurology · doi:10.1016/0014-4886(86)90252-9 · Cited by 40
Serial Cognitive Profiles in Levodopa-induced Hypersexuality
Harvey, N. S. (1988) · The British Journal of Psychiatry · doi:10.1192/bjp.153.6.833 · Cited by 37
Nausieda, P. A. (1985) · Clinical Neuropharmacology · doi:10.1097/00002826-198512000-00002 · Cited by 33
Bauer, L. O. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01111.x · Cited by 32
Levodopa Dependence: A Case Report
Priebe, S. (1984) · Pharmacopsychiatry · doi:10.1055/s-2007-1017418 · Cited by 27
Levodopa Dependence and Abuse in Parkinson's Disease
Spigset, O., & von Scheele, C. (1997) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1997.tb03794.x · Cited by 25
Tack, E., Cuypere, G. D., Jannes, C., & Remouchamps, A. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb06347.x · Cited by 18
Habal, R., Sauter, D., Olowe, O., & Daras, M. D. (1991) · The American Journal of Emergency Medicine · doi:10.1016/0735-6757(91)90125-4 · Cited by 13
Pathological gambling in Parkinson's disease
O’Sullivan, S. S., & Lees, A. J. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70089-3 · Cited by 11
A pilot trial of levodopa/carbidopa in early cocaine abstinence.
Wolfsohn, R., & ANGRIST, B. M. (1990) · PubMed · Cited by 11
Neurochemical changes in cocaine withdrawal
Kuhar, M. J. (1996) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(96)10024-9 · Cited by 10
Ross, R. G., & Ward, N. G. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90234-q · Cited by 10
Cited by
Impulse Control Disorders in Parkinson Disease: A Cross-Sectional Study of 3090 Patients
Weintraub, D., Koester, J., Potenza, M. N., Siderowf, A. D., Stacy, M., Voon, V., Whetteckey, J., Wunderlich, G. R., & Lang, A. E. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.65 · Cited by 1,487
Association of dopamine agonist use with impulse control disorders in Parkinson disease
Weintraub, D., Siderowf, A. D., Potenza, M. N., Goveas, J., Morales, K. H., Duda, J. E., Moberg, P. J., & Stern, M. B. (2006) · Archives of Neurology · doi:10.1001/archneur.63.7.969 · Cited by 662
Circuit Mechanisms of Parkinson’s Disease
McGregor, M. M., & Nelson, A. B. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.004 · Cited by 624
Fractionating impulsivity: neuropsychiatric implications
Dalley, J. W., & Robbins, T. W. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.8 · Cited by 607
Pathological Gambling Caused by Drugs Used to Treat Parkinson Disease
Dodd, M. L., Klos, K. J., Bower, J. H., Geda, Y. E., Josephs, K. A., & Ahlskog, J. E. (2005) · Archives of Neurology · doi:10.1001/archneur.62.9.noc50009 · Cited by 563
Metadata
- Authors
- Giovannoni, G.
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2000-04-01
- Volume
- 68
- Issue
- 4
- Pages
- 423-428
- ISSN
- 0022-3050 (ISSN-L)
- OpenAlex
- W2152767944
- Cited by
- 587
- References
- 36
- FWCI
- 5.55
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.